Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) View Full Press Release Travere Therapeutics to Present at the Stifel 2026 Virtual Immunology and Inflammation Forum Travere Nominated for Inaugural Prix Galien USA Patient First Award